To include your compound in the COVID-19 Resource Center, submit it here.

Alnylam raises $700M in follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) raised $700 million late Monday through the sale of 5.6

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE